|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2010-10-26
|
|
pubmed:abstractText |
This multicenter, open-label, single-arm trial assessed the efficacy of the combination of amlodipine 10 mg and valsartan 160 mg to provide additional blood pressure reduction and tolerability in patients with moderate hypertension not adequately responding to the combination of ramipril 5 mg and felodipine 5 mg.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1651-1999
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
13-21
|
|
pubmed:meshHeading |
pubmed-meshheading:20973652-Aged,
pubmed-meshheading:20973652-Amlodipine,
pubmed-meshheading:20973652-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:20973652-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:20973652-Antihypertensive Agents,
pubmed-meshheading:20973652-Blood Pressure,
pubmed-meshheading:20973652-Calcium Channel Blockers,
pubmed-meshheading:20973652-Felodipine,
pubmed-meshheading:20973652-Female,
pubmed-meshheading:20973652-Humans,
pubmed-meshheading:20973652-Hypertension,
pubmed-meshheading:20973652-Male,
pubmed-meshheading:20973652-Middle Aged,
pubmed-meshheading:20973652-Ramipril,
pubmed-meshheading:20973652-Tetrazoles,
pubmed-meshheading:20973652-Treatment Outcome,
pubmed-meshheading:20973652-Valine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination.
|
|
pubmed:affiliation |
Department of Internal Medicine, Starnberg Hospital, Starnberg, Germany. Peter.Trenkwalder@klinikum-starnberg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
